Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania

Descrizione del progetto

Stimolare la ricerca traslazionale sui tumori solidi pediatrici

I tumori solidi possono presentarsi in molte parti del corpo, quali le ossa, i tessuti e vari organi; inoltre, alcune tipologie quali il neuroblastoma e il tumore di Wilms si sviluppano esclusivamente nei bambini. L’Ospedale universitario Santaros Klinikos di Vilnius (VULSK) in Lituania coordinerà il progetto TREL, finanziato dall’UE, il quale intende potenziare la ricerca traslazionale, clinica e sugli effetti tardivi per i tumori solidi in età pediatrica. L’obiettivo di TREL è rafforzare l’eccellenza scientifica nell’ambito dei tumori solidi pediatrici più comuni (tumori del cervello, neuroblastoma e tumori dei reni). Nel complesso, il progetto mirerà a migliorare il profilo di ricerca del VULSK e ad aumentare la visibilità e la competitività internazionali, regionali e nazionali di tale struttura ospedaliera. Grazie al miglioramento degli indicatori di ricerca, si adopererà inoltre per migliorare il tasso di sopravvivenza per i bambini a cui è stato diagnosticato un tumore solido.

Obiettivo

Vilnius University Hospital Santaros Klinikos (VULSK) acts as a coordinator of the TREL (Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania) project that aims to enhance translational, clinical and late-effect research in paediatric solid tumours (ST). The project concept is based on the existing shortcomings in paediatric oncology at VULSK and Lithuania – scarce research indicators and inferior survival rates in children with ST. TREL has a goal to increase scientific excellence in the most common paediatric ST (brain tumours, neuroblastoma and renal tumours). VULSK and 8 leading research intensive institutions each covering different areas of the project activities according to their expertise form the TREL consortium. TREL will be delivered in 7 working packages addressing training in tumour specific laboratory research and clinical trials, cross-cutting education on genome-wide sequencing and treatment innovations, enhancing skills in observational studies on the quality of survivorship including fertility preservation and research methodology as well as project and innovation management. Training exercise will focus on the implementation of secondments of VULSK staff to the partner premises, organisation of multidisciplinary transfer-of-knowledge meetings, and participation in strategic scientific meetings corresponging objectives of each working package. As a consequence of the twinning activities with internationally-leading research active counterparts VULSK will improve its research profile and reputation, enhance international, regional and national visibility and competitiveness. Fostering of existing and establishment of new networking channels will facilitate incorporation of VULSK professionals to the ongoing collaborative projects that will improve research indicators of individual researchers and VULSK as well as will increase survival rate of children with ST in Lithuania in a long-term perspective.

Invito a presentare proposte

H2020-WIDESPREAD-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-WIDESPREAD-2020-5

Meccanismo di finanziamento

CSA - Coordination and support action

Coordinatore

VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS
Contribution nette de l'UE
€ 465 902,50
Indirizzo
SANTARISKIU G 2
LT-08661 Vilnius
Lituania

Mostra sulla mappa

Regione
Lietuva Sostinės regionas Vilniaus apskritis
Tipo di attività
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Collegamenti
Costo totale
€ 465 902,50

Partecipanti (9)